IFNG and neoplasm: Furthermore, type II (gamma) interferon pathway was activated upon niraparib treatment together with type I (alpha) interferon pathway consistently in several models suggesting the potential elevation of IFN gamma expression within tumor and tumor-microenvironment upon niraparib treatment.